510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0163-2014Class II

Portex Saddleblock Tray with Drugs 22g Quincke (Without Introducer); 4792-20 The Regional Anesthesia family...

Abbott Medical / initiated 2013-09-23 / Terminated / root cause: manufacturing process

Smiths Medical ASD, Inc. began a recall of Portex Saddleblock Tray with Drugs 22g Quincke (Without Introducer); 4792-20 The Regional Anesthesia family of products is comprised of sterile (unless... on . FDA classified it as Class II and gives the reason as "Visual particulate in the glass ampules of 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Ampoule, NDC # 0409-4712-01, Hospira Lot Number 23-227-DK. These ampules are included in certain Portex Spinal...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0163-2014
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Abbott Medical
Product
Portex Saddleblock Tray with Drugs 22g Quincke (Without Introducer); 4792-20 The Regional Anesthesia family of products is comprised of sterile (unless otherwise indicated in the product scope), single-use devices designed to perform epidural, spinal, combined epidural/spinal, nerve block, lumbar puncture and regional anesthesia procedures. The spinal products are comprised of spinal needles, introducer needles and accessories required to perform a spinal procedure.
Product code
CAZ Anesthesia Conduction Kit
Reason for recall
Visual particulate in the glass ampules of 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Ampoule, NDC # 0409-4712-01, Hospira Lot Number 23-227-DK. These ampules are included in certain Portex Spinal Anaesthesia Trays.
Root cause tag
manufacturing process
FDA root cause
Material/Component Contamination
Action
Smiths Medical sent an Urgent Recall Notice dated September 23, 2013, to all affected customers. The notice identified the product, the problem, and the action to be taken by the customer. Customers were instructed to inspect their inventory for the affected product and remove from use. Complete the Confirmation Form and return by fax to 603-358-1017 or by email to [email protected]. Upon receipt of the completed form, a customer service representative would contact them to arrange for exchange of their unused affected devices for credit or replacement. Customers were also instructed to forward the notice to all personnel who need to be aware within their organization. Customers with questions were instructed to contact Smiths Medical's Customer Service Department at 800-258-5361. For questions regarding this recall call 800-258-5361.
Quantity in commerce
200
Distribution
Nationwide Distribution including AK, AR, AZ, CA, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, RI, SC, TX, UT, VA, VT, WA, WI, WY.
Product codes and lots
Lot: 2450793

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0163-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0156-2014Class IITerminatedVoluntary: Firm initiated
Z-0157-2014Class IITerminatedVoluntary: Firm initiated
Z-0158-2014Class IITerminatedVoluntary: Firm initiated
Z-0159-2014Class IITerminatedVoluntary: Firm initiated
Z-0160-2014Class IITerminatedVoluntary: Firm initiated
Z-0161-2014Class IITerminatedVoluntary: Firm initiated
Z-0162-2014Class IITerminatedVoluntary: Firm initiated
Z-0163-2014Class IITerminatedVoluntary: Firm initiated
Z-0164-2014Class IITerminatedVoluntary: Firm initiated